DCPLA-ME is widely used in the field of biomedical research due to its potential therapeutic properties. It has shown promise in studies related to neuroprotection, making it a candidate for treating neurodegenerative diseases such as Alzheimer's and Parkinson's. The compound exhibits anti-inflammatory and antioxidant effects, which can help in reducing neuronal damage caused by oxidative stress and inflammation. Additionally, DCPLA-ME has been investigated for its role in enhancing cognitive functions and memory retention, making it a potential agent for improving brain health. Its application extends to preclinical studies where it is used to understand the mechanisms of neuroprotection and to develop new therapeutic strategies for various neurological disorders.